Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
View stock
VS
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
View stock

Stock highlights

Stock comparison highlights
Stock name
GSK plcJohnson & Johnson
Last price
£17.59$254.47
Currency
GBP
USD
£71B$617B
15.0729.68
£1.18$8.63
0.290.23
£0.67$5.28
3.77%2.09%
Sector
HealthHealth
Employees
66,841138,200
Ticker
£GSK$JNJ
Primary listing
LSENYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in £GSK or $JNJ on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.